DEC Research News
Menu
  • Chemicals
  • Electronics
  • Energy & Power
  • Food
  • Healthcare
  • Manufacturing
  • Technology
Top Stories :
  • ICR renews strategic partnership with Merck for R&D of novel cancer drugs
  • TotalEngeries announces plans to invest in the Adani Green projects
  • Accenture announces the expansion of its partnership with Workday
  • India's ONGC discloses plans of spending $24.2B on clean energy projects
  • Vroozi signs Procure-to-Pay Agreement to expand in Asia & Europe
  • Caller ID software Truecaller introduces call-answering feature powered by AI
  

Latest

LIBERTY Dental Plan expands its teledentistry program in Nevada
Healthcare
Saipriya Iyer Date: March 20, 2020

LIBERTY Dental Plan expands its teledentistry program in Nevada

Amidst the increasing lockdown measures being imposed to curb the spread of coronavirus, LIBERTY Dental Plan of California, Inc. still remains fully functional to address all the emergency dental need....
Aurinia sets up US commercial operations center for voclosporin launch
Healthcare
Saipriya Iyer Date: March 18, 2020

Aurinia sets up US commercial operations center for voclosporin launch

Aurinia Pharmaceuticals Inc., a late-stage biopharma firm involved in the development of voclosporin in several indications, recently announced that it has set up its U.S. commercial operations center....
IMS launches OrgHive to address the concerns on health and wellness
Healthcare
Saipriya Iyer Date: March 17, 2020

IMS launches OrgHive to address the concerns on health and wellness

IMS DV, the venture capital subsidiary of IMS (integrated management system), has recently launched its product authentication platform, dubbed OrgHive, allowing consumers to make healthier lifestyle ....
CureVac to develop mRNA-based COVID-19 vaccine to curb global pandemic
Healthcare
Saipriya Iyer Date: March 16, 2020

CureVac to develop mRNA-based COVID-19 vaccine to curb global pandemic

CureVac AG, a renowned German biopharmaceutical company, has reportedly announced that it is focusing on developing mRNA-based medications as therapeutics as well as vaccines for the coronavirus. The....
Tiziana to accelerate development of TZLS-501 for COVID-19 treatment
Healthcare
Saipriya Iyer Date: March 13, 2020

Tiziana to accelerate development of TZLS-501 for COVID-19 treatment

Tiziana Life Sciences is reportedly set to rapidly develop TZLS-501, an anti-IL6R (anti-interleukin-6 receptor) mAb (monoclonal antibody), for the treatment of COVID-19 infected patients. This anti-IL....
InMed reveals enrollment completion of Phase 1 INM-755 clinical trial
Healthcare
Saipriya Iyer Date: December 03, 2018

InMed reveals enrollment completion of Phase 1 INM-755 clinical trial

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, has recently reported the enrollment completion of Phase 1 clinical trial of INM-755 in healthy subjects. INM-755 is a cannabinol c....
U.S. officials estimate over 1000 cases of coronavirus in the country
Healthcare
Saipriya Iyer Date: March 11, 2020

U.S. officials estimate over 1000 cases of coronavirus in the country

Even though it started with China, the effects of coronavirus can now be seen on a global scale. While numerous countries are trying to contain the spread of the disease, cases of coronavirus infectio....
Valneva receives FDA approval to extend IXIARO® shelf life to 3 years
Healthcare
Saipriya Iyer Date: March 09, 2020

Valneva receives FDA approval to extend IXIARO® shelf life to 3 years

Valneva SE, a specialty vaccine company, has recently announced the FDA (Food & Drug Administration)’s approval regarding the extension of IXIARO®’s shelf life to 36 months (3 years) from 24 ....
China approves use of Roche’s Actemra to treat coronavirus patients
Healthcare
Saipriya Iyer Date: March 07, 2020

China approves use of Roche’s Actemra to treat coronavirus patients

China has recently approved the use of Roche Holding AG’s Actemra, an anti-inflammation drug, in a clinical trial for the treatment of complications arising from coronavirus. The country has been....

Posts navigation

‹ First<7273747576>Last ›

Information

  • About us
  • Contact us
  • Privacy Policy
  • Editorial Policy
  • Our Team

Connect With Us

  •    Facebook
  •    Twitter
  •    Linked-In

Physical Address

  • 1887 WHITNEY MESA DR #4112
    HENDERSON , NV 89014
    e-Mail: [email protected]
DEC Research News Copyright © 2021.